BioNTech, Pfizer Begin German Part of COVID-19 Vaccine Study BioNTech, Pfizer Begin German Part of COVID-19 Vaccine Study

Biotech firm BioNTech said on Monday it widened an ongoing pivotal global study of its COVID-19 vaccine candidate to include testing in its home country of Germany.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news